Consistent with having AD pathology, AD+ classifications were more likely to have ADD, progress to MCI/ADD, be older, and have ≥1 APOE ε4 alleles, compared to AD− and Intermediate statuses (Table 3B). This evidence concerns the gene APOE and Alzheimer disease.